2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
US6124317A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | Nov 18, 1998 |
| Grant date | Sep 26, 2000 |
| Priority date | — |
| Expiry date | Nov 18, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 2-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 2-substituted piperidine analogs as selectively active antagonists of N-methyl-D-aspartatc (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, anxiety, convulsions, amioglycoside antibiotics-induced hearing loss, migraine headaches, chronic pain, glaucoma, CMV retinitis, psychosis, urinary incontinence, opioid tolerance or withdrawal, or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.